Skip to main content
OpenTrials
Completed

NCT Number: NCT04848103

Effect of Extracorporeal Shock Wave Therapy After Arthroscopic Rotator Cuff Repair

Although radial extracorporeal shock wave therapy (rESWT) has proven to be an effective treatment, the effectiveness of the treatment has so far been controversial. There are no studies using rESWT in rehabilitation after arthroscopic rotator cuff repair (ARCR). Therefore, in this study, there is evidence that rESWT promotes pain control and healing recovery, and through previous studies, we would like to investigate whether treatment with rESWT during the intensive rehabilitation period of patients after ARCR is more effective in controlling pain.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Better Hospital

Gwangju, 61085, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults over 18 years old
  • In case of 6 weeks after receiving arthroscopic rotator cuff repair
  • When the participants wishes to enroll in the study

Exclusion criteria

  • 65 years old or older
  • If the tear area is large and augmentation is performed
  • If there is a previous surgical history at the surgical site
  • Osteoarthritis in the shoulder joint

Treatment and study plan

Radial extracorporeal shockwave therapy

Behavioral

Radial extracorporeal shockwave therapy group include Therapeutic modality(Transcutaneous electrical nerve stimulation [TENS], Microwave thermotherapy, and Superficial heat therapy), Range of motion exercise(Continuous passive motion and Active range of motion exercise).

Primary outcomes

  1. . Pain intensity

    Time frame: Change from baseline pain intensity at 2 weeks

    A numeric pain rating scale (NPRS) consisting of 11 points in total from 0 points (no pain) to 10 points (the most severe pain imaginable) is used. The lower the score, the less the pain.

Sponsors and collaborators

Lead sponsor

Sahmyook University

Other

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Apr 19, 2021
Registry last updated
Jul 13, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.